View the SEMAGLUTIDE registration information details.
Back to drug list
ItemsDrug Registration information
ID830
No830
Brand NameSEMAGLUTIDE
IngredientsSEMAGLUTIDE 14 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 30 AND 32'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR TREATMENT OF TYPE 2 DIABETES FOR PATIENTS 18 YEARS OF AGE, TO MAINTIN A STABLE BLOOD SUGAR LEVEL
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE COLORED, FILM COATED TABLET, WITH BREAKLINE ON ONE SIDE AND PLAIN ON THE OTHER
Note
License OwnerFACTORY NO. 3
ManufacturerFACTORY NO. 3
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No02 L 1307/25
FDD Registration Date25/02/2025
Expiry Date24/02/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA